Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Our next phase of growth focuses on deepening technology adoption
MOVIN Express, through its specialised MOVIN Healthcare vertical is addressing needs with time-critical delivery solutions, validated temperature-controlled packaging and real-time shipment monitoring. Dr Dilip Sharma, Chief Operating Officer (COO), MOVIN Express, discusses how the company is transforming healthcare logistics and addressing the evolving needs of Indiaâs pharma industry The post Our next phase of growth focuses on deepening technology adoption appeared first on Express Pharma.
Read Full Article
Express Pharma
VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA
Calls for scientific validation of Ayurveda, highlights child health as a national priority The post VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA appeared first on Express Pharma.
Read Full Article
Pharma Tech
Rare disease regulation reaches âinflection pointâ with new FDA framework
The tailored framework arrives amid renewed focus on rare diseases across US health agencies.
Read Full Article
Express Pharma
Zydus launches Season 3 of âEasiest Examâ campaign to promote breast cancer awareness
The campaign will also feature oncologists sharing insights on early detection, timely screening and treatment, while highlighting the important role of caregiver The post Zydus launches Season 3 of âEasiest Examâ campaign to promote breast cancer awareness appeared first on Express Pharma.
Read Full Article
Pharma Tech
QCi and INmune Bio partner to study XPro in Alzheimerâs
INmune Bio and QCi have agreed to collaborate using quantum computing, AI, and data analytics to explore new indications for XPro, an investigational treatment for Alzheimer's disease and other medical conditions.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Oct 15, 2026, 12:30 PM
Rezolute Reports Enrollment Completion in P-III (upLIFT) Trial of Ersodetug in Tumor Hyperinsulinism
Shots: Ref: Globenewswire |  Image: Rezolute  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Rezolute Reports Enrollment Completion in P-III (upLIFT) Trial of Ersodetug in Tumor Hyperinsulinism appeared first on PharmaShots.
PharmaShots
Oct 15, 2026, 11:30 AM
Ocugen and Roots Pharmaceutical Finalize OCU400 Licensing Deal for Retinitis Pigmentosa in MENA Region
Shots: Ref: Globenewswire |  Image: Ocugen & Roots Pharmaceutical | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ocugen and Roots Pharmaceutical Finalize OCU400 Licensing Deal for Retinitis Pigmentosa in MENA Region appeared first on PharmaShots.
Express Pharma
Oct 15, 2026, 11:18 AM
Our next phase of growth focuses on deepening technology adoption
MOVIN Express, through its specialised MOVIN Healthcare vertical is addressing needs with time-critical delivery solutions, validated temperature-controlled packaging and real-time shipment monitoring. Dr Dilip Sharma, Chief Operating Officer (COO), MOVIN Express, discusses how the company is transforming healthcare logistics and addressing the evolving needs of Indiaâs pharma industry The post Our next phase of growth focuses on deepening technology adoption appeared first on Express Pharma.
Express Pharma
Oct 15, 2026, 11:02 AM
VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA
Calls for scientific validation of Ayurveda, highlights child health as a national priority The post VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA appeared first on Express Pharma.
Pharma Tech
Oct 15, 2026, 10:44 AM
Rare disease regulation reaches âinflection pointâ with new FDA framework
The tailored framework arrives amid renewed focus on rare diseases across US health agencies.
PharmaShots
Oct 15, 2026, 10:30 AM
Elevar Therapeutics Resubmits US FDA NDA for Camrelizumab + Rivoceranib to Treat 1L uHCC
Shots: Ref: Globenewswire |  Image: Elevar Therapeutics | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Elevar Therapeutics Resubmits US FDA NDA for Camrelizumab + Rivoceranib to Treat 1L uHCC appeared first on PharmaShots.
News
Latest industry coverage
Google News
Oct 15, 2026, 9:16 PM
Global pharma firms walk back innovative drug investments in Japan - Nikkei Asia
Global pharma firms walk back innovative drug investments in Japan  Nikkei Asia
Google News
Oct 15, 2026, 9:08 PM
us judge bars copies of lilly weight-loss drug - BusinessWorld Online
us judge bars copies of lilly weight-loss drug  BusinessWorld Online
Google News
Oct 15, 2026, 8:50 PM
The Week in Health: IMSS Pay Dispute, Mental Health, and GLP-1 - Mexico Business News
The Week in Health: IMSS Pay Dispute, Mental Health, and GLP-1Â Â Mexico Business News
Google News
Oct 15, 2026, 8:44 PM
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute - Bloomberg Law News
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute  Bloomberg Law News
Google News
Oct 15, 2026, 8:36 PM
Biotechâs Education Mandate - Pharmaceutical Executive
Biotechâs Education Mandate  Pharmaceutical Executive
Google News
Oct 15, 2026, 8:20 PM
NorthStar, Quarkmed Pair to Expand No-Carrier-Added Actinium-225 Commercial-Scale Access - Contract Pharma
NorthStar, Quarkmed Pair to Expand No-Carrier-Added Actinium-225 Commercial-Scale Access  Contract Pharma
Google News
Oct 15, 2026, 8:18 PM
India's patent power casts new shadow over drug pricing - MLex
India's patent power casts new shadow over drug pricing  MLex
Google News
Oct 15, 2026, 6:41 PM
Choroid Plexus Organoid Differentiation Kits Market To 2035: Growth Driven by CNS Drug Discovery Demand - News and Statistics - IndexBox
Choroid Plexus Organoid Differentiation Kits Market To 2035: Growth Driven by CNS Drug Discovery Demand - News and Statistics  IndexBox
Google News
Oct 15, 2026, 5:44 PM
Managing PFAS In Pharmaceutical Manufacturing A Risk Management Approach For The Pharmaceutical Industry - Med Device Online
Managing PFAS In Pharmaceutical Manufacturing A Risk Management Approach For The Pharmaceutical Industry  Med Device Online
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer